Cite
MLA Citation
Edward B. Garon et al.. “Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.” Lung cancer, vol. 123, 2018, pp. 91–98. http://access.bl.uk/ark:/81055/vdc_100066554498.0x000050